Skytrofa is a prescription growth hormone medication specifically approved for children ages 1 year and older weighing at least 25 pounds who have a diagnosed growth hormone deficiency. This ...
Novo Nordisk’s Sogroya is now approved for children aged 2.5 or older with idiopathic short stature, small for gestational age, and Noonan Syndrome.
Growth hormone helps children grow in height and supports healthy metabolism. When a child does not have enough of this hormone, their growth may be slow. This is sometimes called growth failure.
Skytrofa is a long-acting form of somatropin. Somatropin is also called human growth hormone. Skytrofa is also considered a pegylated somatropin product. Pegylated means the medication is attached to ...
Dear Doctor K: I’m a 77-year-old man. I’ve read about the effects of growth hormone, and they sound great. Is there a downside? Dear Reader: I’ve also seen the many “anti-aging” claims associated with ...
On the 25th, in front of a growth clinic in Seocho District, Seoul. A 10-year-old girl surnamed Park came out after finishing a consultation with her grandmother. The grandmother repeatedly told her ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results